Machine signal
Active cluster sell — 4 distinct insiders, $1.2M, window ends Aug 28, 2026.
Figures computed from official regulatory filings — .
Analysttarget 74.31 USD (+95%) · consensus 4.74/5 · 18 buy · 1 hold · 0 sell
Ownershipinsiders 0.16% · institutions 107.34% · short 6.7% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Xenon Pharmaceuticals Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders. Its product candidates include Azetukalner, a novel, potent Kv7 potassium channel opener which is in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. In addition, the company's Phase 1 Single Ascending Dose/Multiple Ascending Dose products include XEN1701 targeting the sodium channel and XEN1120 targeting the Kv7 potassium channel for the treatment of pain. The company has a license and collaboration agreement with Neurocrine Biosciences, Inc. for the development of NBI-921355, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
55 buys120 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Kelly Thomas Patrick | Buy | $559.7K | conv 99First in 12mo |
| SEC |
| MORTIMER IANtrack record | Buy | $1.1M | conv 98Unusual sizeFirst in 12mo | SEC |
| Graham Dawntrack record | Exercise | $41.9K | SEC |
| Graham Dawntrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| KENNEY CHRISTOPHER JOHN | Sell | $42.7K | SEC |
| KENNEY CHRISTOPHER JOHN | Sell | $383.1K | Unusual size | SEC |
| GANNON STEVENtrack record | Sell | $640.6K | Unusual size | SEC |
| Cannon Gillian | Sell | $63.2K | SEC |
| PATOU GARY | Sell | $70.3K | SEC |
| GAROFALO ELIZABETH A. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Graham Dawntrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Graham Dawntrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Gover Justin D. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cannon Gillian | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Gover Justin D. | Exercise | n/a (No price was disclosed in the filing) | SEC |
| GAROFALO ELIZABETH A. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PATOU GARY | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Machado Clarence Patricktrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cannon Gillian | Exercise | n/a (No price was disclosed in the filing) | SEC |
| PATOU GARY | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Machado Clarence Patricktrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Gover Justin D. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Graham Dawntrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Machado Clarence Patricktrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Gover Justin D. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |